Order Article Reprints

Kavetsou E, Pitterou I, Dimitrioglou NG, Kikionis S, Kritsi E, Zoumpoulakis P, Pontiki E, Hadjipavlou-Litina D, Hatziavramidis DT, Detsi A. Formulation of Pharmaceutical Tablets Containing β-Cyclodextrin-4-Methyl-Umbelliferone (Hymecromone) Inclusion Complexes and Study of the Dissolution Kinetics. Micro. 2023; 3(4):892-911. https://doi.org/10.3390/micro3040061

Kavetsou, Eleni, Ioanna Pitterou, Nikos G. Dimitrioglou, Stefanos Kikionis, Eftichia Kritsi, Panagiotis Zoumpoulakis, Eleni Pontiki, Dimitra Hadjipavlou-Litina, Dimitris T. Hatziavramidis, and Anastasia Detsi. 2023. "Formulation of Pharmaceutical Tablets Containing β-Cyclodextrin-4-Methyl-Umbelliferone (Hymecromone) Inclusion Complexes and Study of the Dissolution Kinetics" Micro 3, no. 4: 892-911. https://doi.org/10.3390/micro3040061

Kavetsou, E., Pitterou, I., Dimitrioglou, N. G., Kikionis, S., Kritsi, E., Zoumpoulakis, P., Pontiki, E., Hadjipavlou-Litina, D., Hatziavramidis, D. T., & Detsi, A. (2023). Formulation of Pharmaceutical Tablets Containing β-Cyclodextrin-4-Methyl-Umbelliferone (Hymecromone) Inclusion Complexes and Study of the Dissolution Kinetics. Micro, 3(4), 892-911. https://doi.org/10.3390/micro3040061